期刊文献+

血友病患者健康教育管理模式初探 被引量:5

A tentative study on health education management mode for hemophilia patients
下载PDF
导出
摘要 目的帮助血友病患者养成健康的生活习惯,去除或减少影响健康及威胁生命的危险因素。方法根据血友病患者的特征,制定个性化健康教育计划,用图、文、多媒体等形式长期反复强化教育内容,帮助患者和家属确定健康信念,建立健康行为。患者根据年龄阶段分为儿童组(n=13)、青少年组(n=19)和成人组(n=27),统计健康教育前后各组患者健康意识(问卷调查)、出血次数以及预防治疗情况。结果教育后健康意识增强(P<0.01),接受预防治疗患者增加(P<0.01),教育后出血次数降低,生活质量提高(P<0.01)。但随着教育间歇期的延长,儿童组及青少年组患者及家属掌握健康知识减少或淡忘,治疗的依从性下降(教育前后比较分别P<0.05和P<0.01)。结论健康教育管理能够促使血友病患者及家属建立正确的疾病预防意识、减少各种出血的发生,提高生活质量,值得临床推广应用。 Objective To help hemophilia patients form healthy lifestyle and avoid or de- crease risks that affect health or threaten life. Methods Based on the characteristics of hemophilia patients, a personalized health education program was made. The program was designed to reinforce educational contents, determine health beliefs and establish healthy behaviors by means of pictures, documents, multimedia and other methods over a long period. According to their ages, the patients were divided into child group (n = 13), teenage group (n = 19) and adult group (n = 27). The health awareness (survey), bleeding counts and preventive and therapeutic measures before and af- ter health education were investigated. Results After health education, the health awareness was enhanced (P〈 0.01 ), the number of patients who accepted preventive therapy increased (P 〈 0. 01), bleeding counts were reduced and life quality was improved (P(O. 01). However, with pro- longed educational interval, mastery of health knowledge and treatment compliance were weakened in the child group and teenage group (P 〈 0.05 and P 〈 0.01 respectively). Conclusion Health e- ducation management can reinforce the awareness of disease prevention, reduce the incidence of bleeding, improve the life quality of patients and their families. Thus it is worthy of clinical applica- tion.
出处 《实用临床医药杂志》 CAS 2012年第16期65-67,70,共4页 Journal of Clinical Medicine in Practice
关键词 血友病 健康教育 管理 hemophilia health education management
  • 相关文献

参考文献10

  • 1王兆钺.血友病诊治的进展与展望[J].临床血液学杂志,2004,17(2):63-66. 被引量:16
  • 2陈玉华,黄晓宇.血友病病人健康教育沟通模式效果评价[J].护理研究(下旬版),2011,25(3):796-797. 被引量:4
  • 3Ikkala E, Helske T, MyUyla G, et al. Changes in the life ex- pectancy of patients with severe, haemophilia A in Finland in 1930 - 1979[J]. Br J aematol, 1982, 52(1 ) : 7. 被引量:1
  • 4Mattanla M, First R, Rosendaal M D. Mortality in Patients with Hemophilia: Changes in a Dutch Population form 1986 to1992 and 1973 to 1986[J]. Ann Intern Med, 1995, 123 (11): 823. 被引量:1
  • 5中华医学会编著..临床诊疗指南 血液学分册[M].北京:人民卫生出版社,2006:145.
  • 6CARCAO M D, ALEDORT L M. Prophylaxis in the hemophilia population - optimizig therapy [ J ]. Haemophilia, 2007, 13: 227. 被引量:1
  • 7MANCO-JOHNSON MJ, PETTERSSON H, PETRINI P, et al. Physical therapy and imaging outcome measures in a hemophilia population treated with factor prophylaxis: cur- rent status and future directions [J]. Hemophilia, 2004, 10 (Supp 1.4): 88. 被引量:1
  • 8蒋连霞,蒋连彩.血友病的临床护理[J].现代中西医结合杂志,2000,9(24):2542-2542. 被引量:6
  • 9史健.血友病患者的健康教育及护理[J].中国实用医药,2010,5(4):231-231. 被引量:25
  • 10Marnmen Chandy. Treatment Options in the Management of Heamophilia in Developing Countries [ J ]. Heamophilia, 2005, 11(8): 5. 被引量:1

二级参考文献17

  • 1王健民,韩凤来,杨健民,孟沛霖,闵碧荷,邱信芳,卢大儒,薛京伦,周洁民,王肖鹏.血友病乙基因治疗临床研究[J].中华血液学杂志,1994,15(6):282-285. 被引量:18
  • 2陈云弟,王寅文,吴竞生,陈美珏,盛敏,任兆瑞,曾溢滔.因子Ⅷ基因倒位的检测与血友病甲的分子诊断[J].中华血液学杂志,1995,16(9):451-453. 被引量:11
  • 3高志杰,金玉红.血友病合并颅内血肿的护理分析与防范对策[J].吉林医学,2006,27(4):426-426. 被引量:3
  • 4姚景鹏.内科护理学.人民卫生出版社,1999:197-200. 被引量:3
  • 5van den Berg H M, Fischer K. Prophylaxis for severe hemophilia: experience from Europe and the United States. Semin Thromb Hemost, 2003, 29:49-54. 被引量:1
  • 6Mannucci P M. Hemophilia: treatment opinions in the twenty-first century. J Thromb Haemost. 2003. 1:1349-1355. 被引量:1
  • 7Boggio L. Inhibitor development with second generation(sucrose formulated) recombinant factor Ⅷ. Biomed Prog, 2003, 16(Suppl 2):4--6. 被引量:1
  • 8Lusher J M, Lee C A, Kessler C M, et al. The safety and efficacy of B-domain deleted recombinant factor Ⅷ concentrate in patients with severe haemophilia, Haemophilia, 2003, 9:38-49. 被引量:1
  • 9Lethagen S. Desmopressin in mild Hemophilia A: indications, limitations, efficacy, and safety. Semin Thromb Hemost, 2003, 29 :101 - 106. 被引量:1
  • 10Oranwiroon S, Akkarapatumwong V, Pung-Amritt P,et al. Determination of hemophilia A carrier by mutation analysis. Haemophilia, 2001, 7:20-25. 被引量:1

共引文献46

同被引文献34

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部